AbbVie stock had its Relative Strength (RS) Rating upgraded from 69 to 76 Thursday -- a welcome improvement, but still shy of the 80 or higher score you prefer to see. See if AbbVie stock can continue to rebound and clear that threshold. Is AbbVie Stock A Buy?
The Dow Jones Industrial Average fell 1.2%, or 380 points, after strong jobs data. The S&P 500 fell 1.4% at 12 p.m. ET in the stock market today. IBD 50 stock Capital Southwest slid below the 50-day line with a 3.5% drop in heavy volume.
Here are the details on Costco’s deal – and what a key investor says to buy instead.
BYD already beats Tesla when it comes to total sales. Now it's closing the gap on purely battery-powered cars as well.
As Treasury yields continue climbing, the stock market seems to be taking a break. But according to CNBC's Jim Cramer, this pullback in stocks could represent an opportunity for investors. In a recent "Mad Money" segment, Cramer explained why rising Treasury yields have been causing problems for stocks. "Why own stocks when you can make north of 4.5% risk-free from the 10-year? Ten-year Treasuries are like a great dividend stock that's guaranteed not to lose money over the next decade," he said.
Tesla introduced a cheaper new version of its popular Model Y SUV just in time to address what some are calling slowing EV sales around the globe.
(Reuters) -A New Jersey appeals court on Tuesday threw out a $223.8 million verdict against Johnson & Johnson that a jury had awarded to four plaintiffs who claimed they developed cancer from being exposed to asbestos in the company's talc powder products. The Superior Court of New Jersey, Appellate Division found that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors at trial. J&J Worldwide Vice President of Litigation Erik Haas said in a statement that the decision "resoundingly rejects ... the 'junk science' advanced by purported 'experts' paid by the mass tort asbestos bar."
Recently, Zacks.com users have been paying close attention to NIO Inc. (NIO). This makes it worthwhile to examine what the stock has in store.
Tesla quietly relaunches a rear-wheel-drive version of its popular Model Y car in the U.S. The car starts at $43,990. It's great for car buyers. Whether or not it's great for investors is tougher to say.
Short sellers are back and are betting these stocks are ready to sell off. These growth stocks all hit recent hit highs.
The Nasdaq led losses as rising Treasury yields piled on pressure and investors got a reminder not to expect a Fed rate cut any time soon.
When the stock market was soaring, dividends of a few percent probably didn't seem like much. But in 2022 — when the benchmark S&P 500 tumbled nearly 20% — many investors learned the hard way that stocks don't always go up. In the unpredictable stock market, investors may find solace in the steady rhythm of dividends. With the right dividend stocks, investors can bypass the stress and uncertainty associated with attempting to time the market, all while benefiting from a passive income stream. Bu
The bulls took hold of the stock market narrative at the start of the year, and charged ahead all the way into mid-summer, but since then the bears have been rather noisy. On the back of rising oil prices, fears of interest rates staying high for longer than hoped for, and the possible prospect of a recession still looming, the markets have been shaky and have been handing back prior gains. However, against a backdrop of a ‘Goldilocks economy,’ i.e., “not too hot, not too cold… just right,” bill
In the latest trading session, Palantir Technologies Inc. (PLTR) closed at $15.88, marking a -0.75% move from the previous day.
The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.
At age 99, Berkshire Hathaway Inc. Vice Chairman Charlie Munger has lived through significant events in history and witnessed numerous economic cycles. Despite his vast experience and candid nature, it's his perspective on optimism that stands out. Known for his sharp wit and incisive one-liners, Munger quips, "If I can be optimistic when I'm nearly dead, surely the rest of you can handle a little inflation." Trending: Until 2016 it was illegal for retail investors to invest in high-growth start
Retiring at age 62 and filing for Social Security will reduce a person’s lifetime benefits by up to 30% compared to waiting until their full retirement age. However, a person with $2.5 million in a Roth IRA may feel more comfortable retiring at age 62, despite the impact that early retirement will have on their […] The post I Have $2.5 Million in a Roth IRA and Will Receive $2,500 Monthly From Social Security. Can I Retire at 62? appeared first on SmartReads by SmartAsset.
Devon Energy (DVN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The 10-year U.S. government bond, or Treasury, is yielding a high of 4.5%. “It’s a lot easier than 20 years ago when you had to call a broker and set the parameters to have them sell you the bond directly,” said Brian Spinelli, co-chief investment officer at Halbert Hargrove, a California wealth-management firm.
In the classic tune by Kenny Rogers, ‘The Gambler,’ he sang, ‘Every hand’s a winner and every hand’s a loser…’ These words hold valuable wisdom that should resonate with every investor. Regardless of your chosen investment strategy, achieving success in the stock market ultimately hinges on mastering the art of balancing risk and reward. Few segments of the stock market offer a higher potential return for the risk involved than the penny stocks, those equities priced at $5 or less. These are sto
It's possible to score 5% yields on CDs. So to even consider dividend paying S&P 500 stocks the yield had better be impressive.
Yahoo Finance 
Yahoo Finance Plus